Cantel Medical Corp. announced the appointment of Karen Prange to the Company's Board of Directors, bringing to the Board more than 25 years of healthcare and life sciences leadership experience. Most recently, Ms. Prange was Executive Vice President and Chief Executive Officer of the Global Animal Health, Medical and Dental Surgical Group at Henry Schein. Ms. Prange previously held senior executive positions at Boston Scientific, as SVP and President of the Urology and Pelvic Health business unit, and at Johnson & Johnson, where she spent 17 years in several cardiovascular, neurovascular and neuroscience medical device businesses. She was also recently appointed to serve on the strategic advisory board of Nuvo Group, an emerging leader in maternal-fetal connected health.